Axcan Pharma Provides Preliminary Revenue Results for the Second Quarter of Fiscal Year 2008

WILMINGTON, DELAWARE--(Marketwire - April 28, 2008) - Axcan Intermediate Holdings Inc., Axcan Pharma Inc.'s parent company (together "Axcan" or the "Company") today announced that revenue for the three-month period ended March 31, 2008 is expected to be within the range of $93 million to $96 million, compared to revenue of $85.3 million for the three-month period ended March 31, 2007. Consistent with its obligations under the indenture for its $228 million 9.25% Senior Secured Notes due 2015, the Company expects to release complete results for its second quarter of fiscal 2008 on or before May 30, 2008.

Back to news